NCT05635734 2026-02-05Azeliragon and Chemoradiotherapy in Newly Diagnosed GlioblastomaCantex PharmaceuticalsPhase 1/2 Active not recruiting18 enrolled
NCT06724926 2026-01-02Concurrent Azeliragon With Craniospinal IrradiationNYU Langone HealthPhase 1 Recruiting32 enrolled